About
This forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.
The programmes are free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.
Breaking News
Gastroenterology Launch is now LIVE! Key Historical Publications and Literature Highlights Available Now
Breaking News
Sarcoidosis Awareness Month
Breaking News
Baricitinib in Juvenile Idiopathic Arthritis: An International, Phase 3, Randomised, Double-blind, Placebo-controlled, Withdrawal, Efficacy, and Safety Trial
Publications
Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
Podcasts
IMID Author Interview: Dr Jake Weddell, 2024
Podcasts
Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar
Podcasts
PsA Podcast: 2023 EULAR recommendations and improvements in PROs with deucravacitinib
Podcasts
IMID Author Interview: Professor Frank Verhoeven, 2024
Publications
Guselkumab provides durable improvement across psoriatic arthritis disease domains: Post hoc analysis of a Phase 3, randomised, double-blind, placebo-controlled study
Podcasts
Discussing RA: April 2024
Publications
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update
Publications
Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: Results from a randomized Phase 2 trial
Publications
Efficacy and safety of risankizumab for active psoriatic arthritis: 100-week results from the Phase 3 KEEPsAKE1 randomized clinical trial
Podcasts
Author Interview: Professor Maria Antonietta D’Agostino, 2024
Podcasts
Author Interview: Professor Dennis McGonagle, 2024
Podcasts
AxSpA Podcast: Secukinumab retention over time & sacroiliac joint improvements between DMARDs
Podcasts
PsA Podcast: Long-term safety of ixekizumab & bimekizumab treatment in a TNFi-IR population
Podcasts
Author Interview: Dr Jürgen Rech, 2024
Podcasts
Discussing Rheumatology: March 2024
Publications
Comparative effectiveness of tofacitinib and adalimumab in axial spondyloarthritis: A real-world clinical context multicenter study
Publications
Long-term efficacy and safety following switch between upadacitinib and adalimumab in patients with rheumatoid arthritis: 5-Year data from SELECT-COMPARE
Publications
Long-term etanercept response for patients with radiographic axial spondyloarthritis based on achievement of early, intermediate, or late responses during index studies
Podcasts
AxSpA Podcast: Risk of Uveitis with Different bDMARDs & PROs following Secukinumab Treatment
Publications
Risk of venous thromboembolism with tofacitinib versus tumor necrosis factor inhibitors in cardiovascular risk-enriched rheumatoid arthritis patients
Publications
Comparative effectiveness of baricitinib and alternative biological DMARDs in a Swiss cohort study of patients with RA
Podcasts
Discussing Rheumatology: February 2024
Podcasts
PsA Podcast: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs
Publications
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): A randomised, international, multicentre, double-blind, placebo-controlled trial
Publications
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): Data from the French Multicentre Retrospective FORSYA Study
Publications
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Podcasts
Author Interview: Professor Andrea Rubbert-Roth, 2023
Publications